Stocks to buy in 2026 for long term: Varun Beverages, Sun Pharma among 5 stocks that could give 10-20% return
1/6
Brokerage Recommendations
Brokerages continue to highlight selective opportunities across NBFCs, consumer, pharmaceuticals, banking, and cement, underpinned by steady earnings visibility and sector-specific tailwinds.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
2/6
Emkay Global on L&T Finance
Emkay Global on L&T Finance: Buy| Target Rs 330| LTP Rs 287| Potential Upside 15%
Emkay Global has recommended a Buy on L&T Finance with a target price of ₹330, implying a potential upside of around 15% from the current market price of ₹287.
Emkay Global has recommended a Buy on L&T Finance with a target price of ₹330, implying a potential upside of around 15% from the current market price of ₹287.
3/6
Motilal Oswal on Varun Beverages
Motilal Oswal on Varun Beverages: Buy| Target Rs 600| LTP Rs 419| Potential Upside 15%
Motilal Oswal has maintained a Buy rating on Varun Beverages with a target price of ₹600, indicating a potential upside of about 15% from the current market price of ₹419.
Motilal Oswal has maintained a Buy rating on Varun Beverages with a target price of ₹600, indicating a potential upside of about 15% from the current market price of ₹419.
Amazon Top Deals
POWERED BY
Crompton Ozone 75 Litres Desert Air Cooler for home | Large & Easy Clean Ice Chamber | 4-Way Air Deflection | High Density Honeycomb Pads | Everlast Pump | Auto Fill| 3 Year Brand Warranty
₹9,798Buy Now43%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹18,490Buy Now23%
OFF
4/6
Motilal Oswal on Sun Pharma
Motilal Oswal on Sun Pharma: Buy| Target Rs 2025| LTP Rs 1733| Potential Upside 16%
Motilal Oswal has also reiterated its Buy call on Sun Pharma, setting a target price of ₹2,025, which suggests a potential upside of around 16% from the current market price of ₹1,733.
Motilal Oswal has also reiterated its Buy call on Sun Pharma, setting a target price of ₹2,025, which suggests a potential upside of around 16% from the current market price of ₹1,733.
5/6
Elara Capital on AU Small Finance
Elara Capital on AU Small Finance Bank: Buy| Target Rs 345 (vs Rs 335)| LTP Rs 271| Potential Upside 27%
Elara Capital has maintained its Buy recommendation on AU Small Finance Bank, raising the target price to ₹345 from ₹335, implying a strong potential upside of approximately 27% from the current market price of ₹271.
Elara Capital has maintained its Buy recommendation on AU Small Finance Bank, raising the target price to ₹345 from ₹335, implying a strong potential upside of approximately 27% from the current market price of ₹271.
6/6
Goldman Sachs on UltraTech Cement
Goldman Sachs on UltraTech Cement: Buy| Target Rs 13,230| LTP Rs 12013| Potential Upside 10%
Goldman Sachs has given a Buy rating on UltraTech Cement with a target price of ₹13,230, indicating a potential upside of about 10% from the current market price of ₹12,013.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Goldman Sachs has given a Buy rating on UltraTech Cement with a target price of ₹13,230, indicating a potential upside of about 10% from the current market price of ₹12,013.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)